Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Obecure Ltd.

www.obecure.com

Latest From Obecure Ltd.

Anti-obesity drugs: an inventor's perspective

After years of anti-obesity disappointments, Orexigen's Contrave, Vivus's Qnexa and Arena's lorcaserin stand on the verge of being filed with the US FDA. Professor Michael Cowley, inventor of Contrave and former chief scientific officer of Orexigen, speaks with Scrip's Asher Mullard about his views on the obesity field.

Metabolic Disorders Cardiovascular

Start-Up Previews (07/2007)

A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Start-Ups in Obesity," "New Technologies for Infertility," and "New Zealand Biotech." Plus these Start-Ups Across Health Care: Intelect Medical, N Spine, and Solace Pharmaceuticals.

Start-Ups in Obesity

The unanimous rejection of Sanofi-Aventis' obesity drug rimonabant by an FDA Advisory Committee in June hasn't put off the host of firms, large and small, seeking an answer to the obesity epidemic. Despite the many drug casualties in this area, still, it seems, no approach is ruled out.
BioPharmaceutical

Obecure Ltd.

Israel's Obecure is investigating the potential of a marketed compound, betahistine, in obesity. It's hoping this repositioning approach will both accelerate timelines and help it overcome growing drug safety hurdles.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Obecure Ltd.
  • Senior Management
  • Yaffa Beck , CEO
    Ronit Gross, Dir., Bus. Dev.
    Ami Eyal , MD, Dir., Clin.
  • Contact Info
  • Obecure Ltd.
    Phone: (972) 37534100
    5-7 Shoham St.
    Paz Towers
    Ramat Gan, 52521
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register